Clinical Trial Oversight Summit Boston

Peter Schiemann to speak at the Clinical Trial Oversight Summit, Boston, MA, June 1-3, 2015

The first topic Peter will cover is focusing on the changes in the relationship(s) with your CRO(s) when you implement a Risk-based Monitoring (RbM) approach and how you need to prepare for this new challenge. The second presentation will be about the fundamentals of implementing RbM, e.g.

  • What is the reason for the difficulties that sponsors face when implementing a risk-based approach to monitoring?
  • How can we overcome these difficulties? What are the key elements that need to be considered?
  • How come most of the sponsors cannot realize the cost saving potential that risk-based monitoring promises?
  • What needs to be done to make it happen?
  • With monitoring focused where it really matters, how can we detect real quality improvements?
    • As registered recipient of our newsletter you are eligible for a discount: Mention key code “SPK00” when registering online and you will save $200 off a commercial conference registration / $100 off an academic, hospital or government affiliated registration to any conference at the Clinical Trial Oversight Summit. If you register before May 8th, you are eligible for the lowest conference rate.

      Read more online
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /